Patents by Inventor Emmanuel Bourrier

Emmanuel Bourrier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11993618
    Abstract: The invention relates to complexing agents of formula (I): wherein Chrom1, Chrom2 and Chrom3 are as defined in the description. The invention also relates to lanthanide complexes obtained from these complexing agents.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: May 28, 2024
    Assignee: CISBIO BIOASSAYS
    Inventors: Laurent Lamarque, Jurriaan Zwier, Emmanuel Bourrier
  • Publication number: 20230017272
    Abstract: The invention relates to complexing agents of formula (I): wherein Chrom1, Chrom2 and Chrom3 are as defined in the description. The invention also relates to lanthanide complexes obtained from these complexing agents.
    Type: Application
    Filed: June 11, 2018
    Publication date: January 19, 2023
    Inventors: Laurent LAMARQUE, Jurriaan ZWIER, Emmanuel BOURRIER
  • Publication number: 20220144860
    Abstract: The invention relates to compounds of formula: in which X, Y, L and Ln3+ are as defined in the description.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 12, 2022
    Inventors: Laurent LAMARQUE, Emmanuel BOURRIER, Thomas ROUX, Eric TRINQUET, Elodie DUPUIS
  • Publication number: 20200140413
    Abstract: The invention relates to complexing agents of formula (I): in which Ra, Chrom1, Chrom2 and Chrom3 are as defined in the description. The invention also relates to lanthanide complexes obtained from these complexing agents. The invention can be used for labelling biological molecules.
    Type: Application
    Filed: June 13, 2018
    Publication date: May 7, 2020
    Inventors: Laurent LAMARQUE, Jurriaan ZWIER, Emmanuel BOURRIER
  • Patent number: 10597409
    Abstract: The invention relates to complexing agents of formula (I) in which A1, A2, A3 and R1 are as defined in the description. The invention also relates to lanthanide complexes obtained from said complexing agents. The invention can be used for marking biological molecules.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: March 24, 2020
    Assignees: CISBIO BIOASSAYS, UNIVERSITE PAUL SABATIER, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Laurent Lamarque, Claude Picard, Chantal Galaup, Nadine Leygue, Jurriaan Zwier, Emmanuel Bourrier
  • Publication number: 20180362549
    Abstract: The invention relates to complexing agents of formula (I) in which A1, A2, A3 and R1 are as defined in the description. The invention also relates to lanthanide complexes obtained from said complexing agents. The invention can be used for marking biological molecules.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 20, 2018
    Inventors: Laurent LAMARQUE, Claude PICARD, Chantal GALAUP, Nadine LEYGUE, Jurriaan ZWIER, Emmanuel BOURRIER
  • Patent number: 9024022
    Abstract: The invention relates to compounds of formula (I?): in which A, L2, M and B are as defined in the description. These compounds are substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: May 5, 2015
    Assignee: Cis Bio International
    Inventors: Emmanuel Bourrier, Michel Laget, Laurent Lamarque, Norbert Tinel, Eric Trinquet, Hervé Bazin
  • Publication number: 20110236952
    Abstract: The invention relates to compounds of formula (I?): in which A, L2, M and B are as defined in the description.
    Type: Application
    Filed: September 22, 2009
    Publication date: September 29, 2011
    Applicant: CIS BIO International
    Inventors: Emmanuel Bourrier, Michel Laget, Laurent Lamarque, Norbet Tinel, Eric Trinquet, Hervé Bazin